US 12070510
Injection of single-stranded or self-complementary adeno-associated virus 9 into the cerebrospinal fluid
granted A61KA61K45/06A61K48/0075
Quick answer
US patent 12070510 (Injection of single-stranded or self-complementary adeno-associated virus 9 into the cerebrospinal fluid) held by REGENXBIO INC. expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENXBIO INC.
- Grant date
- Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K45/06, A61K48/0075, A61K9/0085, A61P